Corona virus
Media release

cobas® SARS-CoV-2 Test

The Roche cobas® SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization and is available in markets accepting the CE mark.

COVID-19: samen overwinnen!

Read the latest press release

Officieel statement Diagned

View the general information sheet

Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases

 

Navify group
NAVIFY Tumor Board. Cloud-based platform ter ondersteuning van multi-disciplinair overleg in de oncologie.

Lees meer

Our business

Roche Diagnostics serves customers spanning the entire healthcare spectrum - from commercial laboratories, research institutions and hospitals to physicians and patients.

See more

About Roche

Doing now what patients need next

We believe it's urgent to deliver medical solutions right now - even as we develop innovations for the future.

Our purpose

Get to know Roche

Get a real taste of the business and culture of one of the world's great research-based healthcare companies.

Roche in 60 seconds

Get in touch